Effect of a Low Starch Diet in Patients With Ankylosing Spondylitis
NCT ID: NCT04386538
Last Updated: 2022-01-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
150 participants
INTERVENTIONAL
2022-01-03
2022-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Spondyloarthritis and Nutrition
NCT05289011
Effect of Anti-inflammatory (ITIS) Diet in Rheumatoid Arthritis
NCT04999683
axSEND: Exploring Immune and Microbiota Effects of a Partial Enteral Nutrition Diet in Axial Spondyloarthritis
NCT06460805
Survey About Diet in Chronic Inflammatory Rheumatic Diseases
NCT05283096
Effectiveness of Probiotics in Patients of Mild to Moderate Rheumatoid Arthritis
NCT06594822
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A sample of 300 patients with AS, followed-up at Portuguese Institute of Rheumatology in Lisbon, will be randomly assigned in two groups. The group A will adopt a balanced diet based on the general recommendations for healthy eating by the World Health Organization, for a period of 6 weeks. In Group B will be implemented an individual balanced low starch diet, which is characterized by the significant reduction of starchy food, of at least 40% of the total daily ingested starch.
The change in biometric data, body composition, intestinal Klebsiella will be related to food intake, disease activity and quality of life assessments. These data will be compared between the 2 groups (diet A versus diet B), obtaining measures on the effect of each diet on the analyzed variables.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low Starch Diet (LSD)
Participants will receive the low starch diet program: restricts the daily amount of ingested rich starch food, to a reduction of at least 40% compared to usual daily individual starch intake.
Low Starch Diet (LSD)
6-week balanced diet program, adapted to individual energetic needs, with significant reduction of high content starchy food, naturally present in plant cells, roots, tubers, seeds, beans, legumes, fruits, and highly present in most farinaceous grains, especially in potatoes, corn, rice, pasta, bread, cookies and cakes.
Control
Participants will receive dietary counselling based on general recommendations for healthy eating.
General healthy eating
6-week balanced healthy eating counseling program, according to the World Health Organization recommendations.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Low Starch Diet (LSD)
6-week balanced diet program, adapted to individual energetic needs, with significant reduction of high content starchy food, naturally present in plant cells, roots, tubers, seeds, beans, legumes, fruits, and highly present in most farinaceous grains, especially in potatoes, corn, rice, pasta, bread, cookies and cakes.
General healthy eating
6-week balanced healthy eating counseling program, according to the World Health Organization recommendations.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Available to comply with study protocol
* Ability to read and sign the Informed Consent
* Diagnosis of Ankylosing Spondylitis performed by the rheumatologist, according to the ASAS classification criteria, revised in 2016
* Positive HLA-B27allele
* Stable dose therapy within 3 months before selection
Exclusion Criteria
* Prior or current clinical history of drug or other substances abuse
* Subjects with uncontrolled clinical conditions, like neoplastic diseases, renal failure, liver impairment, uncompensated cardiac disease
* Dietetic restrictions due to religious believes or others incompatible with the study protocol
* Impossibility to attend to the mandatory personal clinical evaluation
* Presence of pacemaker, making impossible to perform the impedance body composition analysis
* Change in therapy during the intervention period
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Portuguese Institute of Rheumatology
UNKNOWN
Centro de Investigação Interdisciplinar Egas Moniz
UNKNOWN
Universidade do Porto
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alexandra Cardoso
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alexandra MT Cardoso, MD
Role: PRINCIPAL_INVESTIGATOR
Universidade do Porto
Maria Leonor Silva, PhD
Role: STUDY_DIRECTOR
Centro de Investigação Interdisciplinar Egas Moniz
Patrícia Padrão, PhD
Role: STUDY_DIRECTOR
Universidade do Porto
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Instituto Português de Reumatologia
Lisbon, , Portugal
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
alexandracardoso
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.